Loss of core 1-derived O-glycans decreases breast cancer development in mice

Journal of Biological Chemistry

Volumn 290, Issue 33, 2015, Pages 20159-20166

  Song, Kai ^a   Herzog, Brett H ^a,b   Fu, Jianxin ^a,c   Sheng, Minjia ^a,d   Bergstrom, Kirk ^a   McDaniel, J Michael ^a   Kondo, Yuji ^a   McGee, Samuel ^a   Cai, Xiaofeng ^a   Li, Ping ^e   Chen, Hong ^a,b   Xia, Lijun ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Jiangsu Institute of Hematology Collaborative Innovation Center of Hematology Key Laboratory of Thrombosis and Hemostasis of Ministry of Health ^*  (China)

^d CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^e CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; MAMMALS;

APICAL SURFACES; BREAST CANCER; BREAST CANCER MODELS; IN-VIVO; MAMMARY GLAND; O-GLYCANS; O-GLYCOSYLATION;

POLYSACCHARIDES;

CORE 1 DERIVED O GLYCAN; GLYCAN; MUCIN 1; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; BREAST TUMOR; CELL PROLIFERATION; DISEASE MODEL; GENETICS; GLYCOSYLATION; METABOLISM; PATHOLOGY; PROTO ONCOGENE;

MUS;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENES, ERBB-2; GLYCOSYLATION; MICE; POLYSACCHARIDES;

EID: 84939617951     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.654483     Document Type: Article

References (29)

1. Brockhausen, I. (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599-604
2. Picco, G., Julien, S., Brockhausen, I., Beatson, R., Antonopoulos, A., Haslam, S., Mandel, U., Dell, A., Pinder, S., Taylor-Papadimitriou, J., and Burchell, J. (2010) Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 20, 1241-1250
3. Müller, S., and Hanisch, F. G. (2002) Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. J. Biol. Chem. 277, 26103-26112
4. Cazet, A., Julien, S., Bobowski, M., Burchell, J., and Delannoy, P. (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 12, 204
5. Springer, G. F. (1997) Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med. 75, 594-602
6. Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., Laszik, Z., Benbrook, D. M., Hanigan, M. H., and Cummings, R. D. (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 68, 1636-1646
7. Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., Woetmann, A., Yin, G., Chen, L., Song, H., Bak, M., Hlady, R. A., Peters, S. L., Opavsky, R., Thode, C., Qvortrup, K., Schjoldager, K. T., Clausen, H., Hollingsworth, M. A., and Wandall, H. H. (2014) Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. U.S.A. 111, E4066-4075
8. Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132
9. Chou, C. H., Huang, M. J., Chen, C. H., Shyu, M. K., Huang, J., Hung, J. S., Huang, C. S., and Huang, M. C. (2015) Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway. Oncotarget 6, 6123-6135
10. Milde-Langosch, K., Schütze, D., Oliveira-Ferrer L, Wikman H, Müller V, Lebok P, Pantel K, Schröder C, Witzel I, Schumacher U. (2015) Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. Breast Cancer Res. Treat. 151, 515-528
11. Fu, J., Wei, B., Wen, T., Johansson, M. E., Liu, X., Bradford, E., Thomsson, K. A., McGee, S., Mansour, L., Tong, M., McDaniel, J. M., Sferra, T. J., Turner, J. R., Chen, H., Hansson, G. C., Braun, J., and Xia, L. (2011) Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J. Clin. Invest. 121, 1657-1666
12. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115
13. Guy, C. T., Cardiff, R. D., and Muller, W. J. (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954-961
14. DeRose, Y. S., Wang, G., Lin, Y. C., Bernard, P. S., Buys, S. S., Ebbert, M. T., Factor, R., Matsen, C., Milash, B. A., Nelson, E., Neumayer, L., Randall, R. L., Stijleman, I. J., Welm, B. E., and Welm, A. L. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17, 1514-1520
15. Lopez-Knowles, E., Zardawi, S. J., McNeil, C. M., Millar, E. K. A., Crea, P., Musgrove, E. A., Sutherland, R. L., and O'Toole, S. A. (2010) Cytoplasmic Localization of beta-Catenin is a Marker of Poor Outcome in Breast Cancer Patients. Cancer Epidem. Biomarkers 19, 301-309
16. Scholzen, T., and Gerdes, J. (2000) The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182, 311-322
17. Hollingsworth, M. A., and Swanson, B. J. (2004) Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60
18. Kufe, D. W. (2009) Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 9, 874-885
19. Kufe, D. W. (2013) MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 32, 1073-1081
20. Gouyer, V., Leteurtre, E., Zanetta, J. P., Lesuffleur, T., Delannoy, P., and Huet, G. (2001) Inhibition of the glycosylation and alteration in the intracellular trafficking of mucins and other glycoproteins by Gal-NAca-O-bn in mucosal cell lines: An effect mediated through the intracellular synthesis of complex GalNAca-O-bn oligosaccharides. Front. Biosci. 6, D1235-D1244
21. Lakshminarayanan, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., and Boons, G. J. (2012) Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine. Proc. Natl. Acad. Sci. U.S.A. 109, 261-266
22. Cao, R., Wang, T. T., DeMaria, G., Sheehan, J. K., and Kesimer, M. (2012) Mapping the protein domain structures of the respiratory mucins: a mucin proteome coverage study. J. Proteome Res. 11, 4013-4023
23. Al Masri, A., and Gendler, S. J. (2005) Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis. Oncogene 24, 5799-5808
24. Denkert, C. (2013) Diagnostic and therapeutic implications of tumor-infiltrating lymphocytes in breast cancer. J. Clin. Oncol. 31, 836-837
25. Loi, S., and MacCallum, P. (2014) Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer. J. Clin. Oncol. 32, 2935-2937
26. Sewell, R., Bäckström, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gätgens, J., Clausen, H., Hansson, G. C., Burchell, J., and Taylor-Papadimitriou, J. (2006) The ST6GalNAc-I sialyltransferase localizes throughout the golgi and is responsible for the synthesis of the tumor-associated Sialyl-Tn O-glycan in human breast cancer. J. Biol. Chem. 281, 3586-3594
27. Julien, S., Adriaenssens, E., Ottenberg, K., Furlan, A., Courtand, G., Vercoutter-Edouart, A. S., Hanisch, F. G., Delannoy, P., and Le Bourhis, X. (2006) ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology 16, 54-64
28. Springer, G. F., Desai, P. R., Murthy, M. S., and Scanlon, E. F. (1979) Human Carcinoma-Associated Precursor Antigens of the Nm Blood-Group System. J. Surg. Oncol. 11, 95-106
29. Burchell, J., Poulsom, R., Hanby, A., Whitehouse, C., Cooper, L., Clausen, H., Miles, D., and Taylor-Papadimitriou, J. (1999) An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9, 1307-1311